Suppression of polyglutamine-induced cytotoxicity in Saccharomyces cerevisiae by enhancement of mitochondrial biogenesis

FASEB Journal

Volumn 24, Issue 5, 2010, Pages 1431-1441

  Ocampo, Alejandro ^a   Zambrano, Andrea ^a   Barrientos, Antoni ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

HAP4; Mitochondrial metabolism; Yeast model

Indexed keywords

ALAMETHICIN; BENZYLSULFONYL FLUORIDE; CYCLOHEXIMIDE; GALACTOSE; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MITOCHONDRIAL PROTEIN; POLYGLUTAMINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HAP4P; UNCLASSIFIED DRUG; CCAAT BINDING FACTOR; HAP4 PROTEIN, S CEREVISIAE; PEPTIDE; SACCHAROMYCES CEREVISIAE PROTEIN;

ARTICLE; BIOGENESIS; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVE SITE; FLUORESCENCE MICROSCOPY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MUTANT; NERVE DEGENERATION; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION INITIATION; WILD TYPE; BIOSYNTHESIS; GENETICS; HUMAN; HUNTINGTON CHOREA; METABOLISM; MITOCHONDRION; OSMOSIS;

SACCHAROMYCES CEREVISIAE;

CCAAT-BINDING FACTOR; HUMANS; HUNTINGTON DISEASE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; OSMOSIS; PEPTIDES; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 77952296549     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-148601     Document Type: Article

References (50)

1. Shao, J., and Diamond, M. I. (2007) Polyglutamine diseases: emerging concepts in pathogenesis and therapy. Hum. Mol. Genet. 16, R115-123
2. Vonsattel, J. P., Myers, R. H., Stevens, T. J., Ferrante, R. J., Bird, E. D., and Richardson, E. P., Jr. (1985) Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559-577
3. The (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72, 971-983
4. DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., and Aronin, N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993
5. Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G. P., Davies, S. W., Lehrach, H., and Wanker, E. E. (1997) Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549-558
6. Slow, E. J., van Raamsdonk, J., Rogers, D., Coleman, S. H., Graham, R. K., Deng, Y., Oh, R., Bissada, N., Hossain, S. M., Yang, Y. Z., Li, X. J., Simpson, E. M., Gutekunst, C. A., Leavitt, B. R., and Hayden, M. R. (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum. Mol. Genet. 12, 1555-1567
7. Nagai, Y., Inui, T., Popiel, H. A., Fujikake, N., Hasegawa, K., Urade, Y., Goto, Y., Naiki, H., and Toda, T. (2007) A toxic monomeric conformer of the polyglutamine protein. Nat. Struct. Mol. Biol. 14, 332-340
8. Wellington, C. L., Ellerby, L. M., Gutekunst, C. A., Rogers, D., Warby, S., Graham, R. K., Loubser, O., van Raamsdonk, J., Singaraja, R., Yang, Y. Z., Gafni, J., Bredesen, D., Hersch, S. M., Leavitt, B. R., Roy, S., Nicholson, D. W., and Hayden, M. R. (2002) Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J. Neurosci. 22, 7862-7872
9. Krobitsch, S., and Lindquist, S. (2000) Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc. Natl. Acad. Sci. U. S. A. 97, 1589-1594
10. Meriin, A. B., Zhang, X., He, X., Newnam, G. P., Chernoff, Y. O., and Sherman, M. Y. (2002) Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J. Cell Biol. 157, 997-1004
11. Landles, C., and Bates, G. P. (2004) Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series. EMBO Rep. 5, 958-963
12. Cui, L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N., and Krainc, D. (2006) Transcriptional repression of PGC-1α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127, 59-69
13. Bence, N. F., Sampat, R. M., and Kopito, R. R. (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552-1555
14. Bennett, E. J., Shaler, T. A., Woodman, B., Ryu, K. Y., Zaitseva, T. S., Becker, C. H., Bates, G. P., Schulman, H., and Kopito, R. R. (2007) Global changes to the ubiquitin system in Huntington's disease. Nature 448, 704-708
15. Duennwald, M. L., and Lindquist, S. (2008) Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity. Genes Dev. 22, 3308-3319
16. Trushina, E., Dyer, R. B., Badger, J. D., 2nd, Ure, D., Eide, L., Tran, D. D., Vrieze, B. T., Legendre-Guillemin, V., McPherson, P. S., Mandavilli, B. S., Van Houten, B., Zeitlin, S., McNiven, M., Aebersold, R., Hayden, M., Parisi, J. E., Seeberg, E., Dragatsis, I., Doyle, K., Bender, A., Chacko, C., and McMurray, C. T. (2004) Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol. Cell. Biol. 24, 8195-8209
17. Panov, A. V., Gutekunst, C. A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., and Greenamyre, J. T. (2002) Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 5, 731-736
18. Giorgini, F., Guidetti, P., Nguyen, Q., Bennett, S. C., and Muchowski, P. J. (2005) A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease. Nat. Genet. 37, 526-531
19. Gu, M., Gash, M. T., Mann, V. M., Javoy-Agid, F., Cooper, J. M., and Schapira, A. H. (1996) Mitochondrial defect in Huntington's disease caudate nucleus. Ann. Neurol. 39, 385-389
20. Brouillet, E., Jacquard, C., Bizat, N., and Blum, D. (2005) 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J. Neurochem. 95, 1521-1540
21. Ruan, Q., Lesort, M., MacDonald, M. E., and Johnson, G. V. (2004) Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitorinduced cell death through a non-apoptotic pathway. Hum. Mol. Genet. 13, 669-681
22. Wang, H., Lim, P. J., Karbowski, M., and Monteiro, M. J. (2009) Effects of overexpression of huntingtin proteins on mitochondrial integrity. Hum. Mol. Genet. 18, 737-752
23. Choo, Y. S., Johnson, G. V., MacDonald, M., Detloff, P. J., and Lesort, M. (2004) Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum. Mol. Genet. 13, 1407-1420
24. Willingham, S., Outeiro, T. F., DeVit, M. J., Lindquist, S. L., and Muchowski, P. J. (2003) Yeast genes that enhance the toxicity of a mutant huntingtin fragment or α-synuclein. Science 302, 1769-1772
25. Solans, A., Zambrano, A., Rodriguez, M., and Barrientos, A. (2006) Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III. Hum. Mol. Genet. 15, 3063-3081
26. Myers, A. M., Pape, L. K., and Tzagoloff, A. (1985) Mitochondrial protein synthesis is required for maintenance of intact mitochondrial genomes in Saccharomyces cerevisiae. EMBO J. 4, 2087-2092
27. Duennwald, M. L., Jagadish, S., Muchowski, P. J., and Lindquist, S. (2006) Flanking sequences profoundly alter polyglutamine toxicity in yeast. Proc. Natl. Acad. Sci. U. S. A. 103, 11045-11050
28. Herrmann, J. M., Stuart, R. A., Craig, E. A., and Neupert, W. (1994) Mitochondrial heat shock protein 70, a molecular chaperone for proteins encoded by mitochondrial DNA. J. Cell Biol. 127, 893-902
29. Barrientos, A., Korr, D., and Tzagoloff, A. (2002) Shy1p is necessary for full expression of mitochondrial COX1 in the yeast model of Leigh's syndrome. EMBO J. 21, 43-52
30. Nicholls, D. G., and Ward, M. W. (2000) Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci. 23, 166-174
31. Herrmann, J. M., Neupert, W., and Stuart, R. A. (1997) Insertion into the mitochondrial inner membrane of a polytopic protein, the nuclear-encoded Oxa1p. EMBO J. 16, 2217-2226
32. Hunter, F. E., Jr., and Smith, E. E. (1967) Measurement of mitochondrial swelling and shrinking-high amplitude. Methods Enzymol. 10, 689-695
33. Ma, L., Vaz, F. M., Gu, Z., Wanders, R. J., and Greenberg, M. L. (2004) The human TAZ gene complements mitochondrial dysfunction in the yeast taz1Delta mutant. Implications for Barth syndrome. J. Biol. Chem. 279, 44394-44399
34. Halestrap, A. P. (1989) The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism. Biochim. Biophys. Acta 973, 355-382
35. McKee, E. E., and Poyton, R. O. (1984) Mitochondrial gene expression in Saccharomyces cerevisiae. I. Optimal conditions for protein synthesis in isolated mitochondria. J. Biol. Chem. 259, 9320-9331
36. Forsburg, S. L., and Guarente, L. (1989) Identification and characterization of HAP4: a third component of the CCAATbound HAP2/HAP3 heteromer. Genes Dev. 3, 1166-1178
37. Fontanesi, F., Jin, C., Tzagoloff, A., and Barrientos, A. (2008) Transcriptional activators HAP/NF-Y rescue a cytochrome c oxidase defect in yeast and human cells. Hum. Mol. Genet. 17, 775-788
38. Lascaris, R., Bussemaker, H. J., Boorsma, A., Piper, M., van der Spek, H., Grivell, L., and Blom, J. (2003) Hap4p overexpression in glucose-grown Saccharomyces cerevisiae induces cells to enter a novel metabolic state. Genome Biol. 4, R3
39. 2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease. Arch. Biochem. Biophys. 410, 1-6
40. McCampbell, A., Taylor, J. P., Taye, A. A., Robitschek, J., Li, M., Walcott, J., Merry, D., Chai, Y., Paulson, H., Sobue, G., and Fischbeck, K. H. (2000) CREB-binding protein sequestration by expanded polyglutamine. Hum. Mol. Genet. 9, 2197-2202
41. Benchoua, A., Trioulier, Y., Zala, D., Gaillard, M. C., Lefort, N., Dufour, N., Saudou, F., Elalouf, J. M., Hirsch, E., Hantraye, P., Deglon, N., and Brouillet, E. (2006) Involvement of mitochondrial complex II defects in neuronal death produced by Nterminus fragment of mutated huntingtin. Mol. Biol. Cell 17, 1652-1663
42. Meriin, A. B., Zhang, X., Miliaras, N. B., Kazantsev, A., Chernoff, Y. O., McCaffery, J. M., Wendland, B., and Sherman, M. Y. (2003) Aggregation of expanded polyglutamine domain in yeast leads to defects in endocytosis. Mol. Cell. Biol. 23, 7554-7565
43. Haynes, C. M., Titus, E. A., and Cooper, A. A. (2004) Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death. Mol. Cell. 15, 767-776
44. Sokolov, S., Pozniakovsky, A., Bocharova, N., Knorre, D., and Severin, F. (2006) Expression of an expanded polyglutamine domain in yeast causes death with apoptotic markers. Biochim. Biophys. Acta 1757, 660-666
45. DuRose, J. B., Scheuner, D., Kaufman, R. J., Rothblum, L. I., and Niwa, M. (2009) Phosphorylation of eukaryotic translation initiation factor 2α coordinates rRNA transcription and translation inhibition during endoplasmic reticulum stress. Mol. Cell. Biol. 29, 4295-4307
46. Sarkar, S., Ravikumar, B., Floto, R. A., and Rubinsztein, D. C. (2009) Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ. 16, 46-56
47. Bauer, P. O., and Nukina, N. (2009) Enhanced degradation of mutant huntingtin by rho kinase inhibition is mediated through activation of proteasome and macroautophagy. Autophagy 5, 747-748
48. Vacher, C., Garcia-Oroz, L., and Rubinsztein, D. C. (2005) Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease. Hum. Mol. Genet. 14, 3425-3433
49. Kaminosono, S., Saito, T., Oyama, F., Ohshima, T., Asada, A., Nagai, Y., Nukina, N., and Hisanaga, S. (2008) Suppression of mutant Huntingtin aggregate formation by Cdk5/p35 through the effect on microtubule stability. J. Neurosci. 28, 8747-8755
50. Taherzadeh-Fard, E., Saft, C., Andrich, J., Wieczorek, S., and Arning, L. (2009) PGC-1α as modifier of onset age in Huntington disease. Mol. Neurodegener. 4, 10